Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Oncotarget|February 10, 2011
A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugsRyuya Murai, Yoko Yoshida, Teruyuki Muraguchi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancerKazumasa Takenaka, Shinya Ishikawa, Yozo Kawano, et al.
The Journal of Biological Chemistry|November 22, 2008
RECK forms cowbell-shaped dimers and inhibits matrix metalloproteinase-catalyzed cleavage of fibronectinAkira Omura, Tomoko Matsuzaki, Kazuhiro Mio, et al.
Oncotarget|April 9, 2016
Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivityGongping Shi, Yoko Yoshida, Kanako Yuki, et al.
Nature Genetics|December 22, 2005
Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumorChiaki Takahashi, Bernardo Contreras, Tsuyoshi Iwanaga, et al.
Journal of Molecular and Cellular Cardiology|October 8, 2013
Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECKJalahalli M Siddesha, Anthony J Valente, Siva S V P Sakamuri, et al.
International Immunology|July 14, 2004
Endomucin, a sialomucin expressed in high endothelial venules, supports L-selectin-mediated rollingHidenobu Kanda, Toshiyuki Tanaka, Masanori Matsumoto, et al.
Neuroscience Letters|October 6, 2009
Transplantation of cultured choroid plexus epithelial cells via cerebrospinal fluid shows prominent neuroprotective effects against acute ischemic brain injury in the ratNaoya Matsumoto, Akihiko Taguchi, Hitoshi Kitayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancerTaku Takeuchi, Michiyoshi Hisanaga, Mitsuo Nagao, et al.
Annals of Surgical Oncology|September 1, 2005
Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancerKazumasa Takenaka, Shinya Ishikawa, Kazuhiro Yanagihara, et al.
Pageof 8